Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Infection Due to Resistant Bacteria”

21 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 21 results

Large-scale testing (Phase 3)Study completedNCT00035269
What this trial is testing

New Antibiotic to Treat Patients With Community-acquired Pneumonia Due to a Specific Bacteria (S. Pneumoniae Pneumonia)

Who this might be right for
Pneumonia, PneumococcalCommunity Acquired InfectionsGram-positive Bacterial Infections
Pfizer 230
Not applicableStudy completedNCT02556190
What this trial is testing

Colistin Pharmacokinetics in Critically Ill Patients During Extended Dialysis

Who this might be right for
Infection Due to Resistant BacteriaAcute Kidney Injury
Hannover Medical School 8
Large-scale testing (Phase 3)Ended earlyNCT00055198
What this trial is testing

Daptomycin for the Treatment of Infections Due to Gram-Positive Bacteria

Who this might be right for
Gram-Positive Bacterial Infections
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 75
Large-scale testing (Phase 3)Ended earlyNCT03580044
What this trial is testing

Efficacy, Safety, and Tolerability of ATM-AVI in the Treatment of Serious Infection Due to MBL-producing Gram-negative Bacteria

Who this might be right for
Serious Bacterial Infection
Pfizer 15
Not applicableNo Longer AvailableNCT01659515
What this trial is testing

Arbekacin Treatment of Adult Patients With Infections Caused by Multidrug-resistant Bacteria

Who this might be right for
Infection Due to Resistant Organism
U.S. Army Medical Research and Development Command
Large-scale testing (Phase 3)Study completedNCT00035854
What this trial is testing

New Antibiotic to Treat Pediatric Patients With Infections Due to a Specific Bacteria (Vancomycin-Resistant Enterococcus)

Who this might be right for
Bacterial Infections
Pfizer 13
Not applicableUnknownNCT03578835
What this trial is testing

Bloodstream Infection Due to Multidrug-Resistant Organisms - Multicenter Study on Determinants of Clinical Outcomes

Who this might be right for
Bloodstream InfectionSeptic Shock
University Hospital Tuebingen 6,000
Not applicableUnknownNCT02456818
What this trial is testing

Assessing the Effect of Contact Isolation on Nosocomial Colonization With ESBL-EC in German Hematology/Oncology Wards

Who this might be right for
Oncology [See Also, Affected System]Hematological DiseaseInfection Due to ESBL Escherichia Coli
University of Cologne 2,264
Not applicableStudy completedNCT00501150
What this trial is testing

Oral Antibiotic Treatment at Home Instead of Intravenous Treatment in Hospital for Resistant Gram Positive Infections

Who this might be right for
Gram-positive Bacterial InfectionsStaphylococcal Infections
Imperial College London 211
Not applicableStudy completedNCT03349268
What this trial is testing

Pulsed UV Xenon Disinfection to Prevent Resistant Healthcare Associated Infection

Who this might be right for
Healthcare Associated InfectionClostridium Difficile InfectionInfection Due to Multidrug Resistant Bacteria
University of Michigan 25,732
Not applicableStudy completedNCT02796716
What this trial is testing

Study of Accuracy of New Diagnostic Technology to Guide Rapid Antibiotic Treatment for Serious Infections

Who this might be right for
INFECTIONSSkin and Subcutaneous Tissue Bacterial InfectionsHealthcare-associated Infection+1 more
Denver Health and Hospital Authority 2,102
Large-scale testing (Phase 3)WithdrawnNCT00911573
What this trial is testing

Study Evaluating Tigecycline Versus Clindamycin Or Vancomycin On Complicated Skin And Skin Structure Infections Including Those Due To Methicillin-Resistant Staphylococcus Aureus (MRSA) In Pediatric Subjects

Who this might be right for
Skin DiseasesInfection
Wyeth is now a wholly owned subsidiary of Pfizer
Not applicableUnknownNCT06036628
What this trial is testing

Resistant Bacteria in Children in France

Who this might be right for
Infection Due to Resistant BacteriaMulti-antibiotic ResistanceAntibiotic Prescription+6 more
Association Clinique Thérapeutique Infantile du val de Marne 1,000
Not applicableStudy completedNCT01296165
What this trial is testing

International Travel and the Spread of Extended-spectrum Beta-lactamase-producing Escherichia Coli

Who this might be right for
Infection Due to Resistant Bacteria
Johann DD Pitout 173
Large-scale testing (Phase 3)Study completedNCT01577862
What this trial is testing

Colistin and Rifampicin for MDR-Acinetobacter

Who this might be right for
Infection Due to Resistant BacteriaPneumonia, Ventilator-AssociatedHospital Acquired Pneumonia+2 more
University of Campania Luigi Vanvitelli 210
Not applicableStudy completedNCT02060513
What this trial is testing

Study of Accuracy of New Diagnostic Technology to Determine Guide Rapid Antibiotic Treatment for Serious Infections

Who this might be right for
InfectionSkin and Subcutaneous Tissue Bacterial InfectionsHealthcare-associated Infection+1 more
Connie Price 2,298
Large-scale testing (Phase 3)Study completedNCT03329092
What this trial is testing

Determine the Efficacy, Safety and Tolerability of Aztreonam-Avibactam (ATM-AVI) ± Metronidazole (MTZ) Versus Meropenem (MER) ± Colistin (COL) for the Treatment of Serious Infections Due to Gram Negative Bacteria.

Who this might be right for
Complicated Intra-abdominal InfectionHosptial Acquired PneumoniaVentilator Associated Pneumonia
Pfizer 422
Post-approval studies (Phase 4)Temporarily pausedNCT03891433
What this trial is testing

Piperacillin/Tazobactam Versus Carbapenems in Non-bacteremic UTI Due to -ESBL-producing Enterobacteriaceae

Who this might be right for
Urinary Tract InfectionsEnterobacteriaceae InfectionsInfection Due to ESBL Bacteria+5 more
Universidad del Norte 198
Not applicableUnknownNCT01208519
What this trial is testing

SATURN 04 Nosocomial Acquisition Study

Who this might be right for
Bacterial ResistanceInfection Resistant to Multiple DrugsStaph Aureus Methicillin Resistant Colonization+1 more
Catholic University of the Sacred Heart 16,680
Not applicableStudy completedNCT01041716
What this trial is testing

Clinical and Microbiological Outcomes of Infections Due to Carbapenem-Resistant Gram-Negative Bacteria

Who this might be right for
Drug Resistance, Microbial
Maimonides Medical Center 300
Load More Results